Optimal timing maximises Paxlovid benefits for treating COVID-19
- Details
- Category: Research
The findings suggest that taking Paxlovid three to five days after COVID-19 symptoms emerge may maximise the drug's ability to reduce viral loads, minimise viral spread and reduce viral rebound.
European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options
- Details
- Category: Pfizer
Researchers develop a new way to safely boost immune cells to fight cancer
- Details
- Category: Research
Immunotherapy is on the rise as a possible solution. Immunotherapy involves harnessing the power of the body's immune system to fight against cancer cells.
How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Details
- Category: Research
The approach, detailed in a feature published in the April issue of Drug Discovery Today, has attracted more than £4m in industry funding, grants and industry awards, on the back of just £0.2m investment from the University's Dynamic Investment Fund (DIF).
Common HIV treatments may aid Alzheimer's disease patients
- Details
- Category: Research
Chun's new research builds on his lab's landmark publication in Nature in 2018 that described how somatic gene recombination in neurons can produce thousands of new gene variants within Alzheimer's disease brains.
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson's disease
- Details
- Category: Bayer
The study met its primary objective, which was to evaluate the safety of a one-time bilateral delivery of AB-1005 directly to the putamen.
Next-generation treatments hitch a ride into cancer cells
- Details
- Category: Research
Finding an effective ASO delivery system is a major challenge. Cancer cells have gatekeeper molecules that stop unwanted substances from entering.
Groundbreaking treatment approach shows promise in hard-to-treat cancers
- Details
- Category: Research
This combined approach, developed by Florida International University cancer researcher Diana Azzam, was used successfully for the first time to guide treatment of relapsed pediatric cancer patients in collaboration with First Ascent Biomedical and Dr. Maggie Fader at the Helen & Jacob Shaham Cancer & Blood Disorders Institute at Nicklaus Children's Hospital in Miami.
This outdated diabetes drug still has something to offer
- Details
- Category: Research
New drug prevents flu-related inflammation and lung damage
- Details
- Category: Research